Quarterly report pursuant to Section 13 or 15(d)

Loan Receivable - Additional Information (Detail)

v3.8.0.1
Loan Receivable - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 31, 2018
Dec. 31, 2017
Loans Receivable, Net $ 10,000,000 $ 10,000,000
Extendable Amount On Credit Facility $ 8,000,000  
Term Of Management Service Agreement 10 years  
Percentage Of Managing Responsible Of Health Plan ship 100.00%  
APC [Member]    
Long-term Line of Credit $ 5,000,000 5,000,000
NMM Business Loan Agreement [Member]    
Long-term Line of Credit $ 5,000,000 5,000,000
Dr. Jay Loan [Member]    
Loans Receivable, Net   $ 10,000,000
Debt Instrument, Interest Rate, Basis for Effective Rate prime rate plus 1%  
Debt Instrument, Interest Rate, Stated Percentage 5.75% 5.50%
Debt Instrument, Payment Terms Interest on the Dr. Jay Loan accrues at a rate that is equal to the prime rate plus 1% (5.75% and 5.50% as of March 31, 2018 and December 31, 2017, respectively) and payable in monthly installments of interest only on the first day of each month until the date that is 3 years following the initial date of funding, at which time, all outstanding principal and accrued interest thereon shall be due and payable in full.  
Debt Instrument, Convertible, Terms of Conversion Feature At any time on or before the date that is one year following the initial funding date of the Dr. Jay Loan, APC-LSMA or its designee shall have the right, but not the obligation, to convert up to $5,000,000 of the outstanding principal amount into shares of Accountables capital stock. At any time after the date that is one year following the funding date, the Dr. Jay Loan may be prepaid at any time. Within three years following the initial funding of the Dr. Jay Loan, APC-LSMA or its designee shall have the right, but not the obligation, to convert the then outstanding principal amount into Accountable shares based on Accountables then-current valuation.